Corteva (CTVA) saw a mix of highs and lows with its market performance, marked by multiple fluctuations in its stock. Multiple entities either bought into or decreased their stakes in the company. For instance, insider figures increased their stake by 79% while companies like Jackson Square Partners and Nikko Asset Management trimmed their holdings. The company's shares witnessed underperformance on certain days, albeit some overperformance instances.
Arcadia Biosciences (RKDA) announced the sale of its Resistant Starch Durum Wheat Trait to Corteva, its stock seeing gains. Additionally, a Corteva executive made significant stock transactions, selling over $2.2 million and buying $1.24 million worth. Outlook for farmer spending on crops remains strong as per Corteva's CEO. There has also been significant growth in Short Interest. Despite mixed results in Q1 2024, Corteva reaffirmed its 2024 guidance. Recently, Corteva declared its quarterly dividend and participated in the 2024 BMO Farm to Market Chemicals Conference.
Corteva CTVA News Analytics from Mon, 09 Oct 2023 07:00:00 GMT to Sun, 19 May 2024 02:43:22 GMT - Rating 7 - Innovation 4 - Information 8 - Rumor 3
